Given the key roles played by LIG1, LIG3 and LIG4 in genomic integrity 8 and the response of cancer cells to therapy, we investigated their role in ovarian cancer pathology and potential as novel therapeutic targets. This evidence concerns the gene LIG1 and ovarian carcinoma.